UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo

Annals of internal medicine, 2024-05, Vol.177 (5), p.JC54

Bates, Eric R

2024

Volltextzugriff (PDF)

Clinically Significant Differences Between P2Y12 Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be Demonstrated

Journal of the American College of Cardiology, 2024-01, Vol.83 (1), p.e9-e10

Bates, Eric R.

2024

Volltextzugriff (PDF)

P2Y12 inhibitor monotherapy 1 to 3 mo after PCI did not differ from standard DAPT for fatal or ischemic events

Annals of internal medicine, 2023-06, Vol.176 (6), p.JC66

Bates, Eric R

2023

Volltextzugriff (PDF)

Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes

JAMA : the journal of the American Medical Association, 2020-10, Vol.324 (16), p.1613

Bates, Eric R.

2020

Volltextzugriff (PDF)

In HFpEF, adding empagliflozin to usual care reduced a composite of CV death or HF hospitalization at a median 26 mo

Annals of internal medicine, 2022-01, Vol.175 (1), p.JC4

Bates, Eric R

2022

Volltextzugriff (PDF)

What Is a Periprocedural Major Adverse Event After PCI and CABG?

JACC. Cardiovascular interventions, 2023-02, Vol.16 (3), p.314-316

Bates, Eric R.

2023

Volltextzugriff (PDF)

In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes

Annals of internal medicine, 2021-03, Vol.174 (3), p.JC30

Bates, Eric R

2021

Volltextzugriff (PDF)

Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes

The New England journal of medicine, 2019-10, Vol.381 (14), p.1373-1375

Bates, Eric R

2019

Volltextzugriff (PDF)

In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes

Annals of internal medicine, 2019-10, Vol.171 (8), p.JC46

Bates, Eric R

2019

Volltextzugriff (PDF)

After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placebo

Annals of internal medicine, 2019-06, Vol.170 (12), p.JC62

Bates, Eric R

2019

Volltextzugriff (PDF)

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2022-01, Vol.79 (2), p.e21

2022

Volltextzugriff (PDF)

Achieving Aspirational Goals in Providing Primary Percutaneous Coronary Intervention Care

JACC. Cardiovascular interventions, 2019-11, Vol.12 (22), p.2269-2271

Bates, Eric R.

2019

Volltextzugriff (PDF)

In myocardial injury after noncardiac surgery, dabigatran reduced vascular events without increasing major bleeding

Annals of internal medicine, 2018-10, Vol.169 (8), p.JC41

Bates, Eric R.

2018

Volltextzugriff (PDF)

Examination of the Neck Veins

The New England journal of medicine, 2021-03, Vol.384 (9), p.e29-e29

2021

Volltextzugriff (PDF)

Left main coronary disease: evolving management concepts

European heart journal, 2022-11, Vol.43 (44), p.4635-4643

2022

Volltextzugriff (PDF)

Clopidogrel–Drug Interactions

Journal of the American College of Cardiology, 2011-03, Vol.57 (11), p.1251-1263

2011

Volltextzugriff (PDF)

Review: In CAD, CABG reduced 5-year mortality more than PCI in multivessel but not left main disease

Annals of internal medicine, 2018-06, Vol.168 (12), p.JC66

Bates, Eric R.

2018

Volltextzugriff (PDF)

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2016-09, Vol.68 (10), p.1082-1115

2016

Volltextzugriff (PDF)

Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent angina

Annals of internal medicine, 2020-08, Vol.173 (4), p.JC15

Bates, Eric R

2020

Volltextzugriff (PDF)

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischem

Circulation (New York, N.Y.), 2016-09, Vol.134 (10), p.e123-e155

2016

Volltextzugriff (PDF)

Stent-Centric View of Stable Ischemic Heart Disease

Circulation. Cardiovascular interventions, 2020-04, Vol.13 (4), p.e009129-e009129

Bates, Eric R

2020

Volltextzugriff (PDF)

Guided early deescalation of antiplatelet treatment was noninferior to usual prasugrel care in PCI-treated ACS

Annals of internal medicine, 2017-12, Vol.167 (12), p.JC69

Bates, Eric R.

2017

Volltextzugriff (PDF)

Balancing the Evidence Base on Coronary Stents

The New England journal of medicine, 2016-09, Vol.375 (13), p.1286-1288

Bates, Eric R

2016

Volltextzugriff (PDF)

1 – 25 von 1.145

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis eBooks A-Z

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(903)
Mit Volltextzugriff
(897)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(611)
Life Sciences & Biomedicine
(527)
Humans
(477)
Cardiovascular System & Cardiology
(239)
Cardiac & Cardiovascular Systems
(233)
Male
(193)
Biological And Medical Sciences
(191)
Female
(189)
Medical Sciences
(183)
Middle Aged
(140)
Aged
(103)
Cardiology. Vascular System
(87)
Treatment Outcome
(79)
General & Internal Medicine
(78)
United States
(76)
Myocardial Infarction - Therapy
(70)
Medicine, General & Internal
(69)
Heart
(68)
Adult
(65)
Risk Factors
(62)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo

Clinically Significant Differences Between P2Y12 Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be Demonstrated

P2Y12 inhibitor monotherapy 1 to 3 mo after PCI did not differ from standard DAPT for fatal or ischemic events

Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes

In HFpEF, adding empagliflozin to usual care reduced a composite of CV death or HF hospitalization at a median 26 mo

What Is a Periprocedural Major Adverse Event After PCI and CABG?

In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes

Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes

After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placebo

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Achieving Aspirational Goals in Providing Primary Percutaneous Coronary Intervention Care

In myocardial injury after noncardiac surgery, dabigatran reduced vascular events without increasing major bleeding

Examination of the Neck Veins

Left main coronary disease: evolving management concepts

Clopidogrel–Drug Interactions

Review: In CAD, CABG reduced 5-year mortality more than PCI in multivessel but not left main disease

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent angina

Stent-Centric View of Stable Ischemic Heart Disease

Guided early deescalation of antiplatelet treatment was noninferior to usual prasugrel care in PCI-treated ACS

Balancing the Evidence Base on Coronary Stents

Aktive Filter

Suchergebnisse filtern